Selective Wealth Management, Inc. Catalent, Inc. Transaction History

Selective Wealth Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 21, 2022	SELL	$72.36 - $113.1 $8,827 - $13,798	-122 Reduced 22.93%	410 $30,000
Q2 2022 Jul 28, 2022	BUY	$87.2 - $114.05 $46,390 - $60,674	532 New	532 $57,000
Q1 2022 Apr 20, 2022	SELL	$94.19 - $124.49 $28,257 - $37,347	-300 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$119.57 - $139.07 $11,957 - $13,907	100 Added 50.0%	300 $38,000
Q3 2021 Oct 27, 2021	BUY	$109.17 - $142.35 $21,834 - $28,470	200 New	200 $27,000
Q3 2020 Oct 21, 2020	SELL	$72.74 - $92.5 $12,147 - $15,447	-167 Closed	0 $0
Q3 2019 Oct 29, 2019	BUY	$47.45 - $58.05 $7,924 - $9,694	167 New	167 $8,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Selective Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Selective Wealth Management, Inc. with notifications on news.